DIALYSIS · CCN 222556

DaVita Burlington Regional Dialysis

BURLINGTON, MA 01803

DialysisProfitDaVita
$5.5M
TOTAL REVENUE
25.0%
OPERATING MARGIN
4 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$5.5M
Total costs
$4.1M
Operating income (rev − costs)
$1.4M
Operating margin
25.0%
Total charges
$5.7M
Total treatments
14,626
Dialysis stations
17

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.82112—
Fistula Rate
DFC_FISTULA_RATE
59.5100—
Five Star Rating
DFC_FIVE_STAR
4——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
3.6340—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
16482—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.33——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
27100—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
20369—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
51.288—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
39.998—
Standardized ED Visits Ratio
DFC_SEDR
0.8454—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
47.543—